Clinical Trial Update: Safety of Polyphenon E in Multiple Sclerosis Pilot Study [Phase 1]

View source ↗

Summary

Phase 1 safety pilot of Polyphenon E in individuals with Multiple Sclerosis has been completed and results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Polyphenon E (sinecatechin)

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2013-06-27